Preliminary
Can We Restore Aging Immune Systems to Make Cancer Drugs Work Better?

This is a thoughtful overview of promising but unproven strategies to restore immune function in older cancer patients, not a definitive study showing they work. The real test will come …

36 /100
This is a review/commentary article with no original data, making it unsuitable for drawing definitive conclusions. The cited trials are …
Preliminary
A protein that clears harmful RNA buildup could be key to aging

A newly discovered enzyme prevents aging-related RNA damage in animals, suggesting a promising target for longevity therapies—but this finding is too recent to confirm and needs independent replication before clinical …

46 /100
This is a very recent publication (Feb 2026) with zero citations—replication has not yet occurred. The abstract emphasizes mouse data …
Promising
A New Blood Test that Predicts Aging and Disease Risk Across Millions of People

This is rigorous work that validates a promising new way to measure biological age using standard blood tests across a large, diverse population. However, it's too early to use this …

63 /100
Zero citation count and very recent publication (Feb 2026) mean long-term replication is pending. Validation cohorts are primarily European ancestry; …
Preliminary
How Caloric Restriction Reshapes Your Metabolism Over 2 Years

This well-designed study provides the first detailed snapshot of metabolic changes during long-term caloric restriction in humans, showing that carbohydrate and fat metabolism shift in time-dependent ways. However, as an …

39 /100
Major limitations: Preprint status with zero citations—no peer review yet. Descriptive/observational in nature; cannot prove causation or functional significance. Cannot …
Promising
Your retinal images may reveal hidden aging and heart-kidney-metabolic disease risk

This is a well-executed observational study showing that an AI-analyzed eye photograph correlates with cardiovascular and metabolic disease risk, but it's not yet proof that this screening tool will help …

58 /100
Cross-sectional design limits causal inference and prospective prediction validity. No preregistration mentioned. AI model trained on one dataset and validated …
Preliminary
A Natural Plant Compound Slows Aging in Worms by Boosting Cellular Cleanup

Corylin shows genuine promise in a worm model by activating well-established longevity pathways, but these are early-stage findings. Don't expect human supplements or treatments from this work alone—much validation in …

41 /100
Primary concern: Model organism only—no mammalian or human data. No baseline pharmacokinetics or bioavailability data reported. Zero citations to date …
Preliminary
Two-phase aging model reveals critical vulnerability period in flies and mice

This preprint offers an intriguing mathematical framework showing aging may involve a dangerous transition point—but it's early-stage work awaiting peer review and replication. If confirmed, it could refocus aging research …

33 /100
Preprint status: not yet peer-reviewed, so findings are preliminary and should be treated as such. Citation count is zero, confirming …
Preliminary
Plant extract Salvia plebeia triggers cellular cleanup and reverses aging signs in mice

A plant extract activates cellular cleanup (autophagy) and reverses aging markers in mice, with a compound called rosmarinic acid identified as the likely active ingredient—an interesting lead, but human studies …

41 /100
Study is entirely preclinical (in vitro and animal model); no human trials. D-galactose-induced senescence is an artificial aging model with …
Promising
Gene activity patterns reveal how some people stay healthy longer

This paper identifies gene-expression patterns associated with healthy aging in long-lived families and develops a clock that predicts mortality risk. It's promising foundational work, but we need independent replication and …

56 /100
Zero citation count suggests this is published very recently (Feb 2026) and awaits independent replication. The replication cohort is substantially …
Preliminary
Can bezisterim slow brain aging in Alzheimer's disease?

An experimental anti-inflammatory drug appears to reverse epigenetic markers of aging in Alzheimer's patients, raising hope for a new longevity-focused therapeutic approach. But this early-stage preprint lacks peer review, has …

31 /100
Preprint only (not peer-reviewed); small sample size; apparent conflict of interest (authors include drug developers); 'favorable trends' language suggests marginal …
Preliminary
Can Young Blood Make You Younger? What Science Actually Shows (and Doesn't)

Young plasma shows real promise in animals, but human clinical evidence is weak and preliminary. The authors warn against treating this as a proven therapy now—rigorous clinical trials are essential …

41 /100
This is a narrative review, not a systematic review or meta-analysis, so selection bias in which papers the authors chose …
Preliminary
How caloric restriction keeps blood-forming stem cells young in mice

This mouse study identifies two key genes (KDR and PU.1) that control how caloric restriction rejuvenates blood stem cells, pointing toward potential drug targets. However, human translation remains uncertain, and …

48 /100
Study limited to male mice only, limiting generalizability. No citations yet (published Feb 2026), so replication status unknown. Functional outcomes …
Preliminary
How a NAD+ mimic activates the aging-linked SIR2 protein through internal communication networks

This computational study maps an intriguing mechanism by which NAD+-mimics could activate SIR2, and identifies a potential drug target—but it's a hypothesis-generating paper, not proof of concept. Experimental validation and …

41 /100
No experimental validation—purely computational predictions without cell culture or biochemical confirmation. Zero citations (very recent publication) means no independent replication …